Vivani Medical (VANI) EBITDA Margin (2014 - 2022)
Vivani Medical (VANI) posted quarterly EBITDA Margin of 244.19% for Q1 2022, down 6650.0% year-over-year from 3.73% in Q1 2021, and up 99.89% quarter-over-quarter from 217812.5% in Q3 2021.
Vivani Medical (VANI) EBITDA Margin (2014 - 2022) Analysis & Trends
Vivani Medical's EBITDA Margin history runs 9 years deep, the most recent figure standing at 244.19% for Q1 2022.
- In Q1 2022, EBITDA Margin fell 6650.0% year-over-year to 244.19%; the TTM figure through Jun 2022 stood at 797.33% (down 54686.0% YoY), while the FY2019 annual figure was 1004.85%, down 49500.0% from the prior year.
- EBITDA Margin for Q1 2022 stood at 244.19%, up from 217812.5% in the prior quarter.
- The five-year high for EBITDA Margin was 100.12% in Q3 2020, with the low at 217812.5% in Q3 2021.
- The 5-year median for EBITDA Margin is 556.5% (2020), against an average of 17382.1%.
- The sharpest annual moves came in 2020 and 2021: EBITDA Margin jumped 151407 bps in 2020, then plunged 21771238 bps in 2021.
- Vivani Medical's EBITDA Margin stood at 502.38% in 2018, then sank by 225 bps to 1635.01% in 2019, then soared by 94 bps to 100.12% in 2020, then tumbled by 217441 bps to 217812.5% in 2021, then soared by 100 bps to 244.19% in 2022.
- Business Quant data shows VANI's EBITDA Margin at 244.19% in Q1 2022, 217812.5% in Q3 2021, and 177.69% in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -244.19% |
| Sep 30, 2021 | -217,812.50% |
| Mar 31, 2021 | -177.69% |
| Sep 30, 2020 | -100.13% |
| Mar 31, 2020 | -556.50% |
| Dec 31, 2019 | -1,635.01% |
| Sep 30, 2019 | -1,614.19% |
| Jun 30, 2019 | -658.42% |
| Mar 31, 2019 | -865.96% |
| Dec 31, 2018 | -502.38% |
| Sep 30, 2018 | -380.50% |
| Jun 30, 2018 | -418.88% |
| Mar 31, 2018 | -1,000.92% |
| Dec 31, 2017 | -239.08% |
| Sep 30, 2017 | -419.19% |
| Jun 30, 2017 | -307.33% |
| Mar 31, 2017 | -748.76% |
| Dec 31, 2016 | -1,452.17% |
| Sep 30, 2016 | -720.25% |
| Jun 30, 2016 | -820.35% |